Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.
Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%
- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. This indicates a minor page update without affecting study content.SummaryDifference0.0%
- Check28 days agoChange DetectedRemoved the banner about government funding and NIH operating status from the page. The study details and page structure remain unchanged.SummaryDifference0.4%
- Check36 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT03913143; the content and structure appear unchanged, including sections on study design, eligibility, locations, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check43 days agoChange DetectedThe screenshots display the same Study Details page for NCT03913143; there are no additions or deletions to core content such as the title, status, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check50 days agoChange DetectedThe new screenshot shows minor UI updates, including a cookie banner. Core study details remain unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.